Ladson, SC, United States of America

Melissa C Herman

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Melissa C Herman: Innovator in Infection Risk Assessment for Dialysis Patients

Introduction

Melissa C Herman is a notable inventor based in Ladson, South Carolina. She has made significant contributions to the field of healthcare, particularly in the area of infection risk assessment for dialysis patients. Her innovative approach aims to enhance patient care and improve health outcomes.

Latest Patents

Melissa holds a patent for "Systems and methods for identifying risk of infection in dialysis patients." This patent describes a method and system for determining a patient's risk of developing an infection. The system involves extracting patient data from various databases corresponding to a pool of patients receiving treatment. It utilizes predictive models to generate a risk score for each patient, which is then compiled into a report for healthcare facilities. This report aids in identifying patients who may require interventional treatment or consultation.

Career Highlights

Melissa is associated with Fresenius Medical Care Holdings, Inc., where she applies her expertise to develop innovative solutions for patient care. Her work focuses on improving the quality of life for patients undergoing dialysis treatment. With her dedication and innovative mindset, she has made a significant impact in her field.

Collaborations

Some of her notable coworkers include Thomas C Blanchard and Len Usvyat. Their collaborative efforts contribute to advancing healthcare solutions and improving patient outcomes.

Conclusion

Melissa C Herman is a pioneering inventor whose work in infection risk assessment for dialysis patients exemplifies the importance of innovation in healthcare. Her contributions are vital in enhancing patient safety and care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…